HCA
46
4
AN
46
3
DRI
45
-12
CI
38
-10
BDX
41
-13
AON
58
-5
GPC
58
2
STZ
47
-3
PX
69
-4
STI
48
9
TRV
53
-2
UA
38
3
PAYX
35
-12
GME
60
5
BIIB
39
-4
NOC
43
-4
FRT
50
2
AMZN
55
3
PFE
19
-4
AFL
44
-4
HCA
46
4
AN
46
3
DRI
45
-12
CI
38
-10
BDX
41
-13
AON
58
-5
GPC
58
2
STZ
47
-3
PX
69
-4
STI
48
9
TRV
53
-2
UA
38
3
PAYX
35
-12
GME
60
5
BIIB
39
-4
NOC
43
-4
FRT
50
2
AMZN
55
3
PFE
19
-4
AFL
44
-4
Financhill
Back

Check Point Software Technologies Vs. Blueprint Medicines Industry Stock Comparison

Sell
49

CHKP
Check Point Software Technologies

Last Price:
$221.86
Seasonality Move:
3.47%
Buy
53

BPMC
Blueprint Medicines

Last Price:
$129.46
Seasonality Move:
1.87%
Sell
49
Check Point Software Technologies (CHKP) is a Sell

Is Check Point Software Technologies a Buy, Sell or Hold?

  • The current Check Point Software Technologies [CHKP] share price is $222.64. The Score for CHKP is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • CHKP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Blueprint Medicines (BPMC) is a Buy

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $129.46. The Score for BPMC is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • BPMC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CHKP Stock Price Chart

What is Check Point Software Technologies's stock price today?

  • The Check Point Software Technologies share price today is $222.64
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CHKP is experiencing buying pressure, which is a positive indicator for future bullish movement.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $129.46
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight buying pressure.

CHKP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 60.19 Buy
Relative Strength Index (14 RSI): 52.08 Buy
Chaikin Money Flow: 521265 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (216.96 - 223.72) Buy
Bollinger Bands (100): (215.16 - 227.48) Buy

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.49 Buy
Relative Strength Index (14 RSI): 76.66 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (128.07 - 129.15) Buy
Bollinger Bands (100): (85.79 - 122.45) Buy

CHKP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 218.74 Buy
20-day SMA: 220.64 Buy
50-day SMA: 222.19 Buy
200-day SMA: 207.18 Buy
8-day EMA: 201.69 Buy
20-day EMA: 139.17 Buy
50-day EMA: 72.68 Buy
200-day EMA: 21 Buy

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 129.38 Buy
20-day SMA: 128.73 Buy
50-day SMA: 119.37 Buy
200-day SMA: 99.85 Buy
8-day EMA: 129.26 Buy
20-day EMA: 127.9 Buy
50-day EMA: 120.09 Buy
200-day EMA: 103.72 Buy

Check Point Software Technologies Earnings Growth & CHKP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.19 per share, an increase next quarter of $0.14 per share, an increase this year of $0.80 per share, and an increase next year of $0.90 per share.

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.52 per share, an increase next quarter of $0.48 per share, an increase this year of $0.60 per share, and an increase next year of $1.59 per share.

Check Point Software Technologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):